Dilunisal was the "inspiration" for the research that led to development of Tafadamis.
September 5
Diflunisal and tafamidis don't actually share the same ingredients — they are chemically different drugs. However, they do share a similar *effect*: both can stabilize the TTR (transthyretin) protein, helping to prevent it from breaking apart and forming harmful amyloid deposits.
Here's how they compare:
- Tafamidis Show Full Answer
Diflunisal and tafamidis don't actually share the same ingredients — they are chemically different drugs. However, they do share a similar *effect*: both can stabilize the TTR (transthyretin) protein, helping to prevent it from breaking apart and forming harmful amyloid deposits.
Here's how they compare:
- Tafamidis (Vyndamax/Vyndaqel) is specifically designed and FDA-approved to stabilize TTR protein in ATTR cardiomyopathy
- Diflunisal is a nonsteroidal anti-inflammatory drug (NSAID) that happens to *also* have TTR-stabilizing properties, though it is not officially approved for amyloidosis
Think of it like two different keys that can open the same lock — different makeup, but a similar action on the TTR protein.
It's worth noting that diflunisal requires close monitoring because it can affect the stomach and kidneys. Regular checkups and lab tests are typically needed for anyone taking it. Always check with a doctor before making any changes to a treatment plan.
September 5
Join
Your Privacy Choices
